Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03779568 · ClinicalTrials.gov registry record · NA
ED50 and ED95 of Isobaric Bupivacaine for Post-Partum Bilateral Tubal Ligation
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT03779568 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 33 participants.
The verdict
NCT03779568, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
Spinal anesthesia is one of the preferred anesthetic techniques for post-partum bilateral tubal ligation (PBTL). Bupivacaine is the most commonly used local anesthetic for neuraxial anesthesia for post-partum tubal ligation. Typically, hyperbaric bupivacaine would be injected into the spinal (intrathecal) space via a spinal needle; however, ongoing medication shortages have resulted in limited availability on a local and national level. One proposed alternative is isobaric bupivacaine; however, studies investigating its use for post-partum bilateral tubal ligation are limited. The purpose of this prospective study is to determine the minimal effective dose (ED50 and ED95) of isobaric bupivacaine for adequate anesthesia during post-partum tubal ligation after vaginal delivery.
Interventions
- OTHER Dose adjustment of bupivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2019-02-25 |
| Est. Completion | 2020-04-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03779568
The ClinicalTrials.gov registry entry for NCT03779568 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dose adjustment of bupivacaine is the first listed.
NCT03779568 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03779568 about?
NCT03779568 is a clinical study titled "ED50 and ED95 of Isobaric Bupivacaine for Post-Partum Bilateral Tubal Ligation". Spinal anesthesia is one of the preferred anesthetic techniques for post-partum bilateral tubal ligation (PBTL). Bupivacaine is the most commonly used local anesthetic for neuraxial anesthesia for post-partum tubal ligation. Typically, hyperbaric bupivacaine would be injected into the spinal (intrat...
What is the current status of trial NCT03779568?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2019-02-25. Estimated completion is 2020-04-09.
What interventions are being tested in trial NCT03779568?
The interventions under investigation include: Dose adjustment of bupivacaine (OTHER).
Who is sponsoring clinical trial NCT03779568?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.